Table of Contents Author Guidelines Submit a Manuscript
International Journal of Rheumatology
Volume 2010 (2010), Article ID 784947, 6 pages
http://dx.doi.org/10.1155/2010/784947
Review Article

Capillaroscopy as an Outcome Measure for Clinical Trials on the Peripheral Vasculopathy in SSc—Is It Useful?

1Research Laboratory and Academic Unit of Clinical Rheumatology, Department of Internal Medicine, University of Genova, Viale Benedetto XV, 6, 16132 Genova, Italy
2Department of Rheumatology, Ghent University Hospital, 9000 Ghent, Belgium

Received 15 May 2010; Accepted 6 July 2010

Academic Editor: Lorinda Chung

Copyright © 2010 Maurizio Cutolo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Cutolo, A. Sulli, and V. Smith, “Assessing microvascular changes in systemic sclerosis diagnosis and management,” Nature Reviews Rheumatology. In press.
  2. A. Herrick and M. Cutolo, “Clinical implications from capillaroscopic analysis in patients with Raynaud's phenomenon and systemic sclerosis,” Arthritis and Rheumatism. In press.
  3. L. Amanzi, F. Braschi, G. Fiori et al., “Digital ulcers in scleroderma: staging, characteristics and sub-setting through observation of 1614 digital lesions,” Rheumatology, vol. 49, no. 7, pp. 1374–1382, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. A. L. Herrick, “Pathogenesis of Raynaud's phenomenon,” Rheumatology, vol. 44, no. 5, pp. 587–596, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. V. Smith, C. Pizzorni, F. De Keyser et al., “Reliability of the qualitative and semiquantitative nailfold videocapillaroscopy assessment in a systemic sclerosis cohort: a two-centre study,” Annals of the Rheumatic Diseases, vol. 69, no. 6, pp. 1092–1096, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Cutolo, W. Grassi, and M. M. Cerinic, “Raynaud's phenomenon and the role of capillaroscopy,” Arthritis and Rheumatism, vol. 48, no. 11, pp. 3023–3030, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Sulli, M. E. Secchi, C. Pizzorni, and M. Cutolo, “Scoring the nailfold microvascular changes during the capillaroscopic analysis in systemic sclerosis patients,” Annals of the Rheumatic Diseases, vol. 67, no. 6, pp. 885–887, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Engelhart and J. K. Kristensen, “Raynaud's phenomenon: blood supply to fingers during indirect cooling, evaluated by laser Doppler flowmetry,” Clinical Physiology, vol. 6, no. 6, pp. 481–488, 1986. View at Google Scholar · View at Scopus
  9. F. M. Wigley, R. A. Wise, J. Mikdashi, S. Schaefer, and R. J. Spence, “The post-occlusive hyperemic response in patients with systemic sclerosis,” Arthritis and Rheumatism, vol. 33, no. 11, pp. 1620–1625, 1990. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Cutolo, C. Ferrone, C. Pizzorni, S. Soldano, B. Seriolo, and A. Sulli, “Peripheral blood perfusion correlates with microvascular abnormalities in systemic sclerosis: a laser-Doppler and nailfold videocapillaroscopy study,” Journal of Rheumatology, vol. 37, no. 6, pp. 1174–1180, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. E. S. Weiner, S. Hildebrandt, J.-L. Senecal et al., “Prognostic significance of anticentromere antibodies and anti-topoisomerase I antibodies in Raynaud's disease: a prospective study,” Arthritis and Rheumatism, vol. 34, no. 1, pp. 68–77, 1991. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. Hamaguchi, “Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis,” Journal of Dermatology, vol. 37, no. 1, pp. 42–53, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. T. Czömpöly, D. Simon, L. Czirják, and P. Németh, “Anti-topoisomerase I autoantibodies in systemic sclerosis,” Autoimmunity Reviews, vol. 8, no. 8, pp. 692–696, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. C. Mihai and J. W.C. Tervaert, “Anti-endothelial cell antibodies in systemic sclerosis,” Annals of the Rheumatic Diseases, vol. 69, no. 2, pp. 319–324, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. E. C. LeRoy and JR. Medsger T.A., “Criteria for the classification of early systemic sclerosis,” Journal of Rheumatology, vol. 28, no. 7, pp. 1573–1576, 2001. View at Google Scholar · View at Scopus
  16. M. Koenig, F. Joyal, M. J. Fritzler et al., “Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis,” Arthritis and Rheumatism, vol. 58, no. 12, pp. 3902–3912, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Cutolo, C. Pizzorni, M. Tuccio et al., “Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis,” Rheumatology, vol. 43, no. 6, pp. 719–726, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. L. Mouthon, C. Mestre-Stanislas, A. Bérezné et al., “Impact of digital ulcers on disability and health-related quality of life in systemic sclerosis,” Annals of the Rheumatic Diseases, vol. 69, no. 1, pp. 214–217, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. V. Smith, C. Pizzorni, F. De Keyser et al., “Validation of the qualitative and semiquantitative assessment of the scleroderma spectrum patterns by nailfold videocapillaroscopy: preliminary results,” Arthritis and Rheumatism, vol. 60, pp. S164–S165, 2009. View at Google Scholar
  20. C. Beyer, G. Schett, S. Gay, O. Distler, and J. H. Distler, “Hypoxia in the pathogenesis of systemic sclerosis,” Arthritis Research & Therapy, vol. 11, no. 2, pp. 220–227, 2009. View at Google Scholar · View at Scopus
  21. S. Alivernini, M. De Santis, B. Tolusso et al., “Skin ulcers in systemic sclerosis: determinants of presence and predictive factors of healing,” Journal of the American Academy of Dermatology, vol. 60, no. 3, pp. 426–435, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Sebastiani, A. Manfredi, M. Colaci et al., “Capillaroscopic skin ulcer risk index: a new prognostic tool for digital skin ulcer development in systemic sclerosis patients,” Arthritis Care and Research, vol. 61, no. 5, pp. 688–694, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. J. G. Coghlan and C. Handler, “Connective tissue associated pulmonary arterial hypertension,” Lupus, vol. 15, no. 3, pp. 138–142, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. H. M. A. Hofstee, A. V. Noordegraaf, A. E. Voskuyl et al., “Nailfold capillary density is associated with the presence and severity of pulmonary arterial hypertension in systemic sclerosis,” Annals of the Rheumatic Diseases, vol. 68, no. 2, pp. 191–195, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. Y. Y. Ong, T. Nikoloutsopoulos, C. P. Bond, M. D. Smith, M. J. Ahern, and P. J. Roberts-Thomson, “Decreased nailfold capillary density in limited scleroderma with pulmonary hypertension,” Asian Pacific Journal of Allergy and Immunology, vol. 16, no. 2-3, pp. 81–86, 1998. View at Google Scholar · View at Scopus
  26. E. L. Greidinger, S. P. Gaine, R. A. Wise, C. Boling, T. Housten-Harris, and F. M. Wigley, “Primary pulmonary hypertension is not associated with scleroderma-like changes in nailfold capillaries,” Chest, vol. 120, no. 3, pp. 796–800, 2001. View at Publisher · View at Google Scholar · View at Scopus
  27. T. Ohtsuka, A. Hasegawa, A. Nakano, A. Yamakage, M. Yamaguchi, and Y. Miyachi, “Nailfold capillary abnormality and pulmonary hypertension in systemic sclerosis,” International Journal of Dermatology, vol. 36, no. 2, pp. 116–122, 1997. View at Google Scholar · View at Scopus
  28. A. J. H. M. Houben, J. H. Beljaars, L. Hofstra, A. A. Kroon, and P. W. De Leeuw, “Microvascular abnormalities in chronic heart failure: a cross-sectional analysis,” Microcirculation, vol. 10, no. 6, pp. 471–478, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. N. J. Davie, R. T. Schermuly, N. Weissmann, F. Grimminger, and H. A. Ghofrani, “The science of endothelin-1 and endothelin receptor antagonists in the management of pulmonary arterial hypertension: current understanding and future studies,” European Journal of Clinical Investigation, vol. 39, supplement 2, pp. 38–49, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Sulli, S. Soldano, C. Pizzorni et al., “Raynaud's phenomenon and plasma endothelin: correlations with capillaroscopic patterns in systemic sclerosis,” Journal of Rheumatology, vol. 36, no. 6, pp. 1235–1239, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. P. Caramaschi, A. Volpe, S. Pieropan et al., “Cyclophosphamide treatment improves microvessel damage in systemic sclerosis,” Clinical Rheumatology, vol. 28, no. 4, pp. 391–395, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Aschwanden, T. Daikeler, K. A. Jaeger et al., “Rapid improvement of nailfold capillaroscopy after intense immunosuppression for systemic sclerosis and mixed connective tissue disease,” Annals of the Rheumatic Diseases, vol. 67, no. 7, pp. 1057–1059, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. I. Miniati, S. Guiducci, M. L. Conforti et al., “Autologous stem cell transplantation improves microcirculation in systemic sclerosis,” Annals of the Rheumatic Diseases, vol. 68, no. 1, pp. 94–98, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. R. De Angelis, W. Grassi, and M. Cutolo, “A growing need for capillaroscopy in rheumatology,” Arthritis Care and Research, vol. 61, no. 3, pp. 405–410, 2009. View at Publisher · View at Google Scholar · View at Scopus